Samrat Pharmachem's Evaluation Adjusted Amid Mixed Technical Signals and Strong Financial Performance

Apr 22 2025 08:04 AM IST
share
Share Via
Samrat Pharmachem, a microcap in the Pharmaceuticals & Drugs sector, has experienced a recent evaluation adjustment. This change considers the company's technical indicators and financial performance, highlighting strong management efficiency and consistent positive results over the past quarters, amidst a complex market landscape.
Samrat Pharmachem, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in evaluation. This revision reflects a nuanced assessment of the company's technical indicators and market position.

The stock has demonstrated a mixed technical landscape, with the MACD showing varying signals across different time frames. While the weekly MACD leans towards a mildly bullish stance, the monthly perspective remains bearish. The Relative Strength Index (RSI) has not indicated any significant signals in both weekly and monthly assessments. Additionally, Bollinger Bands suggest a sideways movement in the short term, while the longer-term view appears mildly bearish.

Despite these technical nuances, Samrat Pharmachem has reported positive financial performance in its latest quarter, showcasing strong management efficiency with a high return on capital employed (ROCE) and a low debt-to-EBITDA ratio. The company has consistently declared positive results over the last four quarters, indicating a stable operational foundation.

Overall, the adjustment in evaluation reflects a comprehensive analysis of both technical trends and the company's financial health, positioning Samrat Pharmachem within a complex market environment.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News